Investigator
National Cancer Institute
Ryan M. Young, PhD, is an investigator in the Lymphoid Malignancies Branch at the National Cancer Institute in Bethesda, Maryland. Dr. Young received his Ph.D. in Biochemistry from Cornell University and pursued post-doctoral training at National Jewish Medical Research Center in Denver, Colorado, and later with Dr. Louis Staudt at the National Cancer Institute. During this time Dr. Young developed a deep mechanistic understanding of how aggressive lymphomas utilize the B cell receptor and mutant isoforms of MYD88 to promote tumor growth and survival. These insights have helped to refine the use of B cell receptor pathway inhibitors in the clinic. His current research aims to elucidate pathological signaling in lymphoid malignancies, including multiple myeloma and lymphoma, and leverage these discoveries to develop novel diagnostic and therapeutic strategies.